Completed

Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)

The University of Arizona has an existing award for this program and thus is not eligible to apply for additional awards.

Research Category
Funding Type
Internal Deadline
External Deadline
2/17/2026 (LOI); 4/20/2026 (Full Application)

Fund for the Improvement of Postsecondary Education – Special Projects (FIPSE – SP)

Institutionally Coordinated 

National Need Areas:

  1. Advancing the Understanding and Use of Artificial Intelligence (AI) in Postsecondary Education (Absolute Priorities 1 and 2)
  2. Promoting Civil Discourse on College and University Campuses (Absolute Priority 3) 
    C. Simmons (Office of the Provost)
  3. Promoting Accreditation Reform (Absolute Priorities 4 and 5)
  4. Supporting Capacity-Building for High-Quality Short-Term Programs (Absolute Priorities 6 and 7)
    E. Burke (Student Engagement and Career Development)

Limiting Language 
An eligible entity may submit only one (1) grant application under an area of national need as the lead applicant. An entity can be included as a partner in multiple applications. The eligible entity may apply to all four (4) areas of national need as the lead applicant but must submit a separate grant application for each area of national need.

Program Overview
In order to support these four crucial needs, this competition includes seven absolute priorities under which applicants can apply: two priorities dedicated to advancing the understanding and use of AI in postsecondary education (Absolute Priorities 1 and 2), one priority dedicated to promoting civil discourse on college and university campuses (Absolute Priority 3), two priorities within promoting accreditation reform (Absolute Priorities 4 and 5), and two priorities for capacity-building for high-quality short-term programs (Absolute Priorities 6 and 7). The Department intends to award $50 million to advance AI in Education, $60 million to promote civil discourse on college and university campuses, $7 million to support accreditation reform, and $50 million for high-quality short-term programs. The Department may adjust these estimates based on interest and quality of applications.

Research Category
Funding Type
External Deadline
12/3/2025
Solicitation Type

Mathers Foundation Grant - Spring 2026 Cycle

Limit: 3 // Tickets Available: 0

M. Bhattacharya (Neuroscience)
P. Arunachalam (Immunobiology)
N. Lee (Pharmacology)

The mission of The G. Harold and Leila Y. Mathers Foundation is to advance knowledge in the life sciences by sponsoring scientific research that will benefit mankind. The foundation’s grants program seeks to support basic science, ideally with potential translational applications. Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience, etc., are some noteworthy examples of current research support.

For many years the Foundation has enjoyed special recognition in the research community for supporting “basic” scientific research, realizing that true transformative breakthroughs usually occur after a thorough understanding of the fundamental mechanisms underlying natural phenomena. More recently, and with the advent of newer investigative methodologies, technology, and tools, the Foundation now embraces innovative translational research proposals.

The grant duration must be three years. The budget should be reasonable based on the aims of the project. Indirect costs may not exceed 10%. Preliminary Budgets are required during the LOI phase. A detailed budget justification is not required until the proposal phase. The Foundation’s grant award is not intended to be utilized for purchasing capital equipment (“bricks-and-mortar”) for the lab and is intended only to support the actual investigation. The Foundation assumes and expects that capital equipment must be provided by the research institution or university.

Application Guidance:

  • Grant budgets cannot exceed $600-750K
  • The Foundation primarily supports basic science, ideally with potential translational applications.
  • Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience, etc., are some noteworthy examples of current research support.
  • Covid-19-related research projects (aims or sub-aims) will not be considered for support.
  • Medical imaging technology-related projects and/or electrical engineering technology development projects will not be considered for support.
  • Plant Biology Research, Oceanography, Space Exploration. and Global warming-related research will not be considered for support.
  • As technology continues to advance, it is apparent that investigations in the area of basic science and translational research may become more and more reliant on collaborative, interdisciplinary projects. It is important to note that any interdisciplinary project proposals may require additional information regarding the collaborator(s)’ achievements and relevant expertise.
  • Feedback for declined LOI Requests will not be provided; LOIs or Formal Proposals that have been declined should not be resubmitted at a later date for consideration.
  • Renewal applications for the same or related research will not be accorded priority consideration. It is strongly advised that any re-application for grant renewal consider a new direction based on prior research or emphasize some new potential translational aspects and not merely an extension of previously funded research.
  • Requests for funding previously federally supported research and/or applications pending federal approval will not be accorded priority consideration.
  • Requests for support of clinical trials or drug discovery will not be approved. The Foundation will not support projects which we consider pre-clinical drug development.

     
CycleInstitutional Nominations and
Portal Registration
LOI ApplicationInvited Formal Proposals
Spring 2026Jan 30th, 2026
8pm EST
Feb 13th, 2026
8pm EST
Apr 24th, 2026
8pm EST

Please note, while RDS will manage submitting the institutional nomination, it is the responsibility of the selected faculty members to complete the portal registration by the January 30, 2026 at 8pm EST deadline.

Funding Type
Internal Deadline
External Deadline
1/30/2026 (Deadline for selected faculty to complete portal registrations); 2/12/2026 (LOI); 4/24/2026 (Invited Full Applications)

2026 V Foundation Adult Translational and All-Star Translational Cancer Research Award

Limit: 2 // Tickets Available: 1

Translational Research Grant - C. Curiel (Dermatology)

The University of Arizona Cancer Center (UACC) is coordinating this limited submission. For more information please contact: UACC-PreAward. If you have any question concerning eligibility and details regarding the opportunity, please contact the Grants Team at Grants@v.org.

Limiting Language
The University of Arizona Cancer Center (UACC) can nominate up to two proposals: one Translational nominee and one All-Star Translational nominee (if eligible) for the V Foundation Adult Translational Cancer Research Award 2026.


Purpose of Award:

The UACC is seeking nominations for the Translational Adult Cancer Research Grant which advances basic laboratory discoveries towards clinical use, ultimately improving human health.

This grant is restricted to adult cancer research in the preclinical or translational space, with a focus on bench-to-bedside strategies. Research on ANY adult cancer type is eligible. Applicants may propose cancer research projects that:

  • Move a novel strategy from the laboratory into a human clinical trial, or
  • Use specimens from a clinical trial to test hypotheses, develop biomarkers, or establish mechanisms.

The research must apply in a direct way to human beings within 3 years of the grant’s completion. If biomarker research is undertaken, a validation set or independent clinical trial is essential. Proposals must include a plan for biomarker validation, if applicable. The endpoint of the project should be the planning or initiation of a new clinical trial or conducting an investigator-initiated trial with laboratory correlates that test hypotheses. Research areas not included in this scope are epidemiology, behavioral science, and health services research.

Applicant Eligibility

Nominee must meet all of the following criteria by the nomination due date:

  • Be nominated by their Cancer Center Director or similar high ranking research official.
  • Be employed at a non-profit research institution (e.g., 501c3, Section 170).
  • Be a US Citizen or have a legal permit (temporary or permanent) to work in the US.
  • Hold a full-time faculty appointment at the Assistant Professor or Assistant Professor-equivalent level or above. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for Principal Investigator nomination.
  • Additional criteria for All Star eligibility:
    • Must have previously been awarded a V Foundation research grant as the lead PI and must meet at least ONE of the following criteria by the nomination deadline:
      1. Have a completed V Foundation research grant or
      2. Be in the final year of an active V Foundation grant (received final payment and on track to finish by grant end date).
      • Must have been the lead PI on the V Foundation research grant from start to finish.
      • Must have all financial and progress reports up to date.
      • Must not have a current V Foundation All-Star grant.
      • Must not have only received V Foundation non-research/Mission grant(s).

Funding Information:

A four-year, $800,000 grant, paid in $200,000 annual installments. Indirect costs up to 10% of direct costs allowed. For All Star: the total grant award is $1,000,000 over a five-year period, with annual payments of $200,000.

The V Foundation follows NIH salary cap guidelines. Institutions may supplement a grant recipient’s salary with institutional funds, if desired.

Funding Type
Internal Deadline
External Deadline
12/5/2025 (Nomination); 1/9/2026 (Application)
Sponsor
Solicitation Type

Damon Runyon Clinical Investigator Award 2026

Limit: 3 // Tickets Available: 2

K. Huntoon (Neurosurgery)

The University of Arizona Cancer Center (UACC) is coordinating this limited submission. For more information please contact: UACC-PreAward.

Limiting Language
Each applicant must be nominated by their institution. Applications will only be accepted from institutions that have been invited to submit them by the Foundation (See list). Three (3) nominations per institution, including its affiliated schools, will be accepted. 

Purpose of Award

  • The Damon Runyon Clinical Investigator Award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine.

    The Clinical Investigator Award responds to three recognized realities:

    • Though there has never been a more pressing need or more promising time for clinical cancer research, fewer young physicians enter this area of investigation every year.
    • The number of institutions committed to training young physicians in the scientific discipline and methodologies of clinical investigation is critically low.
    • The burden of medical school debt (averaging over $100,000) discourages many physicians from pursuing clinical investigation.

    The Damon Runyon Cancer Research Foundation’s award offers solutions to these realities. The awardee will receive financial support for three years, as well as assistance with certain research costs such as the purchase of equipment. The Foundation will also retire up to $100,000 of any medical school debt still owed by the awardee.

    The Clinical Investigator Award program is specifically intended to provide outstanding young physicians with the resources and training structure essential to becoming successful clinical investigators. The goal is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments.

Eligibility

  • The applicant must hold an independent Assistant Professor position or equivalent at a U.S. institution and is expected to demonstrate significant support from the home institution through a comprehensive start-up package, ample laboratory space, and protected research time, for example.
  • The applicant must have received an MD, DO, or MD/PhD degree(s) from an accredited institution, completed their subspecialty training and be U.S. Board eligible.
  • The applicant must hold a valid, active U.S. medical license at the time of application.
  • The applicant must apply within the first four (4) years of their Assistant Professor or equivalent full-time faculty appointment (Cut-off date: July 1, 2022). Instructor, Adjunct and/or acting positions are not eligible.
  • Candidates holding or awarded R01s (or R01-equivalent grants such as the DP2 and DP5) at the time of application are not eligible to apply.
  • The applicant must commit to spending 80% of their time conducting research. [In rare unique circumstances, the CIA Committee may consider an applicant with a very modest reduction of 80% protected time if their Department Chair can provide a compelling reason explaining why a waiver of the 80% requirement should be granted, what percentage of effort will be guaranteed, and what safeguards will be put in place to make sure the individual’s research will not be compromised by their clinical/administrative activities.]
  • The applicant is required to apply in conjunction with a Mentor who is established in the field of clinical translational cancer research, cancer prevention and/or epidemiology and can provide the critical guidance needed during the period of the award. No more than two Damon Runyon Clinical Investigators will be funded to work with the same Mentor at any given time (including Co-Mentors).
  • Candidates may apply up to two times during this eligibility period.
  • Only one application will be accepted from a Mentor per review session (including Co-Mentors).
Funding Type
Internal Deadline
External Deadline
1/20/2025

FFAR 2026 New Innovator in Food and Agriculture Research Award

Limit: 1 // Tickets Available: 0

A. Favela (Plant Science)

Deadline note: This selection process is running with an anticipated deadline. We will inform all applicants of relevant updates in the guidelines, submission deadlines, and eligibility as soon as more information becomes available.

Limiting Language
Institutions may submit one nominee to the New Innovator Award program.

Eligibility 

  • From the 2025 cycle, subject to change in new RFA release: The nominated faculty member must have been hired on or after August 1, 2021, for a tenure-track or equivalent position and may work in any discipline or any department within the institution.
  • Preference will be given to individuals near the onset of their independent research career and who are within eight (8) years of receiving a Ph.D. or equivalent degree.
  • This research concept must directly benefit U.S. agricultural interests.
  • Individuals with significant research experience prior to obtaining their faculty position will not be considered for this award. For the purpose of this funding opportunity, significant research experience is defined as a nominee that has been awarded a substantial research grant (three to five years of support) or has received project funding totaling over $1M within the time of their tenure position or has been awarded similar career development awards with similar budgetary scope.

Research must align with one of the following priority areas:

  • Cultivating thriving production systems
  • Sustaining vibrant agroecosystems
  • Bolstering healthy food systems
  • Strengthening the scientific workforce 
Funding Type
Internal Deadline
External Deadline
2/19/2026 (Anticipated)

RTX University Research Program - Five (5) RFPs

Limit: 25* // Tickets Available: 10

* RTX has invited the University of Arizona to participate in submission to five (5) topic areas (listed below) for funding of up to $100,000/project. Each institution is limited to five (5) submissions per topic area and each tenure track faculty member may request one limited submissions ticket for one topic area

Autonomy // Limit: 5 // Tickets Available: 0
H. Rastgoftar (Aerospace and Mechanical Engineering)
M. Chertkov (Applied Mathematics)
J. Thanga (Aerospace and Mechanical Engineering)
E. Azimi (Electrical and Computer Engineering)
N. Risso  (Mining Engineering and Mineral Resources)

Advanced Materials and Manufacturing // Limit: 5 // Tickets Available: 1
P. Deymier (Materials Science and Engineering) 
E. Madenci (Aerospace and Mechanical Engineering)
V. Yurkiv (Aerospace and Mechanical Engineering)
B. Chalifoux (Optical Sciences)

Microelectronics // Limit: 5 // Tickets Available: 5

Digital Lifecycle // Limit: 5 // Tickets Available: 3
A. Salado (Systems and Industrial Engineering)
H. Budinoff (Systems and Industrial Engineering)

Integrated Battlespace // Limit: 5 // Tickets Available: 4
B. Bash (Electrical and Computer Engineering)

Program and Submission Details:
For more information on each of these topics of interest, login to box and click here. Please note technical data is strictly prohibited. 

The full submissions consists of: 

  • Acknowledgement of Terms of Use and agreement that no Technical Data is included.
  • 700 Word Description including: relevance of your proposed project to the specific technology needs; how the work will advance the field of research; how the deliverables and outcomes would lead to a continued and deeper research partnership with RTX businesses; opportunities for future collaborations with institutions, organizations, or experts; follow-on funding opportunities and specific funding agencies who would have interest in the technology, and the outcomes necessary to stimulate that interest.
  • Scope of Work (SOW) that breaks down the proposed project into tasks explaining in brief terms how you would secure and allocate resources; how you address any risks, including delays; defined tasks and their associated milestones, schedule, and deliverables.
  • Budget Form 

Topics of Interest: 

  1. Autonomy
  2. Advanced Materials and Manufacturing
  3. Microelectronics
  4. Digital Lifecycle
  5. Integrated Battlespace

Upcoming Informational Webinars
Please note that webinars will not be recorded. If you are unable to attend and have questions, please contact Christine Gemelli, Director for University Relations and Technical Learning at RTX, at christine.gemelli2@rtx.com

New Date:  Microelectronics
Monday November 10, 10 to 11:00 am (Arizona time)
https://www.zoomgov.com/j/16124740608?pwd=Vkk3ZWFSM25COUJMeTRNdU83cktNUT09&omn=1600648772&from=addon
Meeting ID: 161 2474 0608 | Passcode: 615506


Integrated Battlespace
Friday November 7, 1:30 to 2:30 pm (Arizona time)
https://www.zoomgov.com/j/16124740608?pwd=Vkk3ZWFSM25COUJMeTRNdU83cktNUT09&omn=1618313830&from=addon 
Meeting ID: 161 2474 0608 | Passcode: 615506

Advanced Materials and Manufacturing
Monday November 17 1pm to 2 pm (Arizona time)
https://www.zoomgov.com/j/16124740608?pwd=Vkk3ZWFSM25COUJMeTRNdU83cktNUT09&omn=1613346598&from=addon 
Meeting ID: 161 2474 0608 | Passcode: 615506

Digital Lifecycle
Friday, November 7, 8 am to 9 am (Arizona time)
https://www.zoomgov.com/j/16124740608?pwd=Vkk3ZWFSM25COUJMeTRNdU83cktNUT09&omn=1608750769&from=addon
Meeting ID: 161 2474 0608
Passcode: 615506

Autonomy
Friday, November 7, 9 am to 10 am (Arizona time)
https://www.zoomgov.com/j/16124740608?pwd=Vkk3ZWFSM25COUJMeTRNdU83cktNUT09&omn=1609280784&from=addon
Meeting ID: 161 2474 0608
Passcode: 615506
 

Research Category
Funding Type
Internal Deadline
External Deadline
12/2/2025
Sponsor
Solicitation Type

Value Assessment and Health Outcomes Research Predoctoral Fellowship

Limit: 1 per research group

A. Acharya (Epidemiology and Biostatistics) 

Limiting Langauge 
Only one predoctoral applicant per research group may apply for this award. If multiple applicants apply, they will automatically be ineligible. Potential applicants and their thesis advisors should decide who will apply.

Overview 
The PhRMA Foundation’s Predoctoral Fellowship in Value Assessment-Health Outcomes Research (VA-HOR) is designed to support promising students (U.S. and non-U.S. citizens) during advanced stages of training and thesis research in value assessment and health outcomes research.

Funding Type
Internal Deadline
External Deadline
10/30/2025
Solicitation Type

Mellon Foundation - Higher Learning 2026 Open Call for Concepts

Limit: 3 // Tickets Available: 0

J. Duran (Confluence Center for Creative Inquiry)
E. White (Public and Applied Humanities)
J.P. Jones (School of Geography, Development and Environment) 

Limiting Language:
Each institution may submit no more than three applications to Mellon for consideration. 

Eligibility
The Principal Investigator (PI), or applicant, must be a faculty member and/or dean in a program or department in the humanities or humanistic social sciences at the applicant institution. The PI may also be the institution’s provost/chief academic officer. Applications that do not include a CV for the PI will be disqualified from consideration. 

Overview
Full sponsor guidelines are linked here.

In the interest of maintaining a grantmaking portfolio that supports inquiry into issues of vital social, cultural, and historical import, the Higher Learning program at the Mellon Foundation invites eligible institutions of higher education to submit ideas for research and/or curricular projects focused on either of the two areas listed below. Projects should engage teams of scholars and/or students, and have visible, enduring impact at the institution. The two topical areas for the call are:

• Unruly Intelligences
• Normalization and Its Discontents

The Mellon Higher Learning team will review all eligible submissions and invite a small number of the most promising concepts to be developed into full proposals for potential grant funding. In consideration of the anticipated volume of concept submissions, we are unable to provide feedback on preliminary concepts.

Research Category
Funding Type
Internal Deadline
External Deadline
12/1/2025 (registration forms due); 2/17/2026 (full application)
Solicitation Type

SebastianStrong Foundation's Discovery Science Award

No Applicants // Limit: 2 // Tickets Available: 2

Limiting Language
Submissions will be evaluated to ensure they align with our mission and funding criteria. A limit of two proposals may be submitted from the same institution, researcher, or foundation. 

Program Overview
SebastianStrong funds one or more proposals each year that advance meaningful change in pediatric cancer treatment. We are especially interested in research that:

  • Focuses on pediatric cancers with low survival rates or high relapse rates
  • Has transitional potential within 36 months
  • Pursues underfunded or unconventional approaches that could change the status quo
Funding Type
Internal Deadline
External Deadline
11/30/2025 (LOI)
Solicitation Type